✦ LIBER ✦

Treatment of Long-Standing Nocturnal Enuresis by Mandibular Advancement

✍ Scribed by Christopher J. Robertson

Publisher: Springer-Verlag
Year: 2004
Tongue: English
Weight: 95 KB
Volume: 8
Category: Article
ISSN: 1520-9512
DOI: 10.1007/s11325-004-0057-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term treatment of nocturnal enuresi

Long-term treatment of nocturnal enuresis with desmopressin

✍ Knudsen, U. B. ;Rittig, S. ;N�rgaard, J. P. ;Lundemose, J. B. ;Pedersen, E. B. ; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 307 KB

Eight patients with monosymptomatic nocturnal enuresis (age 11-24 years) were investigated prior to and after 24 weeks of desmopressin treatment in order to evaluate the impact on the endogenous vasopressin secretion and urinary output. No effect on plasma vasopressin, diurnal urinary volume, and ur

Efficacy and safety of nasal desmopressi

Efficacy and safety of nasal desmopressin in the long-term treatment of primary nocturnal enuresis

✍ Kenichi Kano; Osamu Arisaka 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 47 KB

Advances in Targeting Drug Delivery to G

Advances in Targeting Drug Delivery to Glomerular Mesangial Cells by Long Circulating Cationic Liposomes for the Treatment of Glomerulonephritis

✍ Katsumi Morimoto; Masayo Kondo; Kazuo Kawahara; Hideto Ushijima; Yasuhiko Tomino 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 518 KB

Phase I/II study of treatment of locally

Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the radiation therapy oncology group (RTOG 83-12): long-term results

✍ Mary V. Graham; Thomas E. Pajak; Arnold M. Herskovic; Bahman Emami; Carlos A. Pe 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Treatment of patients with advanced or b

Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy : Long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-a/b multicenter randomized trial

✍ Malika Djeridane; Stéphane Oudard; Martine Escoffre-Barbe; Laurence Lacotte-Thie 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## BACKGROUND This Phase II study was performed in patients with advanced or bulky Hodgkin disease (HD) to evaluate the results of a 7‐drug chemotherapy (CT) regimen that was administered over 12 weeks according to 2 randomized modalities followed by high‐dose lymph node irradiation.